Skye Bioscience, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Skye Bioscience, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2024.
  • Skye Bioscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $2.09M, a 252% increase year-over-year.
  • Skye Bioscience, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $8.32M, a 742% increase year-over-year.
  • Skye Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $8.32M, a 742% increase from 2023.
  • Skye Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $988K, a 62.4% increase from 2022.
  • Skye Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $608K, a 30% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.32M +$7.33M +742% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $988K +$379K +62.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $608K -$261K -30% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $869K +$566K +187% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $303K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2014 $10.8K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.